XYH-26421-44571
3 vaccinations
2 coded responses
19 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 563 / MN
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Registered in v-safe
-
2021-01-21
Dose 1 — Pfizer-BioNTech
-
2021-01-21
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-22
- 2021-01-23
- 2021-01-25
- 2021-01-27
- 2021-01-28
- 2021-02-04
-
2021-02-10
Dose 2 — Pfizer-BioNTech
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-12
- 2021-02-14
- 2021-02-15
-
2021-02-17
Health check-in — day 7, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-02-24
- 2021-03-10
- 2021-03-17
- 2021-03-24
-
2021-05-14
Survey response — 3 months, dose 2MedDRA: Headache — Feeling: FairFree text: HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-10
Dose 3 — Pfizer-BioNTech
- 2022-02-10
-
2022-10-10
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Had COVID in July 5th 2022. Had booster in July 15th 2022. Recently just got bivalent booster. Experiencing Port COVID SyndromeMedDRA releases: 2024-11 · check-in free text available
-
2022-10-10
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-11
-
2022-10-11
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Pfizer-BioNTech | |
| 2 | 2021-02-10 | Pfizer-BioNTech | |
| 3 | 2021-10-10 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-10 | Successful 2022-10-11 |
Participant prefers to complete VAERS report online |
Free text
Release 8 — 3 months, dose 2
Symptoms: Headache
Release 12 — 12 months, dose 3
Symptoms: Had COVID in July 5th 2022. Had booster in July 15th 2022. Recently just got bivalent booster. Experiencing Port COVID Syndrome
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release